Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT05879211

Goal Concordant Care Learning Laboratory

The goal-concordant care lab will develop and test strategies to optimize communication in advanced serious illness.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

About this study

The goal-concordant care lab will develop and test strategies to optimize communication in advanced serious illness. The lab will test a variety of interventions, including triggered conversations and feedback to healthcare providers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Duke Health patient

Exclusion criteria

  • None

Treatment and study plan

Feedback

Behavioral

Providers will receive detailed feedback about the timing, quality, and frequency of their goals of care communication with patients

Primary outcomes

  1. Frequency of goals of care communication

    Time frame: 2 years

    Frequency of goals of care conversations in the last 6 months of life

  2. Timing of goals of care communication

    Time frame: 6 months

    Proximity of goals of care communication to death

Sponsors and collaborators

Lead sponsor

Duke University

Other

Registry information

Official study title

Palliative Care Learning Laboratory

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
May 30, 2023
Registry last updated
Feb 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.